(Q42546734)

2 November 2017

title

Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey (English)

1 reference

2 November 2017

0 references

1 reference

1 reference

1 reference

Melega WP

1

1 reference

2 November 2017

Raleigh MJ

2

1 reference

2 November 2017

Stout DB

3

1 reference

2 November 2017

Lacan G

4

1 reference

2 November 2017

Huang SC

5

1 reference

2 November 2017

Phelps ME

6

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

2 November 2017

1 reference

2 November 2017

volume

766

1 reference

2 November 2017

issue

1-2

1 reference

2 November 2017

page(s)

113-120

1 reference

6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Longitudinal behavioral and 6-[18F]fluoro-L-DOPA-PET assessment in MPTP-hemiparkinsonian monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Ethological and 6-[18F]fluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

6-[18F]fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Dopa-responsive dystonia: [18F]dopa positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

Long-term effects of chronic methamphetamine administration in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

The assessment of the non-equilibrium effect in the 'Patlak analysis' of Fdopa PET studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900548-9

10.1016/S0006-8993(97)00548-9

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference